Molecular Partners AG | Key People and Executives
William Matt Burns
Chairman
Patrick Amstutz
Chief Executive Officer & Director
William A. Lee
Non-Executive Director
Petri T. Vainio
Non-Executive Director
Steven H. Holtzman
Independent Non-Executive Director
Göran Albert Torstensson Ando
Independent Non-Executive Director
William Matt Burns
Chairman
Patrick Amstutz
Chief Executive Officer & Director
Michael Tobias Stumpp
Chief Operating Officer
Andreas Emmenegger
Chief Financial Officer
Pamela A. Trail
Chief Scientific Officer
Andreas Harstrick
Chief Medical Officer
William A. Lee
Non-Executive Director
Petri T. Vainio
Non-Executive Director
Steven H. Holtzman
Independent Non-Executive Director
Göran Albert Ando
Independent Non-Executive Director
| Address |
Wagistrasse 14
Zurich Zurich 8952
Switzerland
|
|
Employees
|
- |
| Website |
http://www.molecularpartners.com |
| Updated |
07/08/2019 |
| Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun and Michael Tobias Stumpp on November 23, 2004 and is headquartered in Zurich, Switzerland. |
